MDT Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 11.83% compared to Medtronic PLC's net margin of 14.45%. Medtronic PLC's return on equity of 9.51% beat Boston Scientific's return on equity of 9.57%.

Medtronic PLC has a consensus price target of $97.21, signalling upside risk potential of 8.48%. On the other hand Boston Scientific has an analysts' consensus of $117.36 which suggests that it could grow by 13.24%. Given that Boston Scientific has higher upside potential than Medtronic PLC, analysts believe Boston Scientific is more attractive than Medtronic PLC.

Medtronic PLC has a beta of 0.804, which suggesting that the stock is 19.64% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.679, suggesting its less volatile than the S&P 500 by 32.134%.

Medtronic PLC has a quarterly dividend of $0.71 per share corresponding to a yield of 3.14%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic PLC quarterly revenues are $8.9B, which are larger than Boston Scientific quarterly revenues of $4.7B. Medtronic PLC's net income of $1.1B is higher than Boston Scientific's net income of $674M. Notably, Medtronic PLC's price-to-earnings ratio is 24.75x while Boston Scientific's PE ratio is 75.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.45x versus 8.79x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Electromed has a net margin of 11.83% compared to Medtronic PLC's net margin of 12.06%. Medtronic PLC's return on equity of 9.51% beat Electromed's return on equity of 16.57%.

Medtronic PLC has a consensus price target of $97.21, signalling upside risk potential of 8.48%. On the other hand Electromed has an analysts' consensus of $33.50 which suggests that it could grow by 83.76%. Given that Electromed has higher upside potential than Medtronic PLC, analysts believe Electromed is more attractive than Medtronic PLC.

Medtronic PLC has a beta of 0.804, which suggesting that the stock is 19.64% less volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.

Medtronic PLC has a quarterly dividend of $0.71 per share corresponding to a yield of 3.14%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic PLC quarterly revenues are $8.9B, which are larger than Electromed quarterly revenues of $15.7M. Medtronic PLC's net income of $1.1B is higher than Electromed's net income of $1.9M. Notably, Medtronic PLC's price-to-earnings ratio is 24.75x while Electromed's PE ratio is 23.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.45x versus 2.66x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical has a net margin of 11.83% compared to Medtronic PLC's net margin of 30.99%. Medtronic PLC's return on equity of 9.51% beat Intuitive Surgical's return on equity of 15.82%.

Medtronic PLC has a consensus price target of $97.21, signalling upside risk potential of 8.48%. On the other hand Intuitive Surgical has an analysts' consensus of $581.45 which suggests that it could grow by 12.12%. Given that Intuitive Surgical has higher upside potential than Medtronic PLC, analysts believe Intuitive Surgical is more attractive than Medtronic PLC.

Medtronic PLC has a beta of 0.804, which suggesting that the stock is 19.64% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.642, suggesting its more volatile than the S&P 500 by 64.249%.

Medtronic PLC has a quarterly dividend of $0.71 per share corresponding to a yield of 3.14%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic PLC quarterly revenues are $8.9B, which are larger than Intuitive Surgical quarterly revenues of $2.3B. Medtronic PLC's net income of $1.1B is higher than Intuitive Surgical's net income of $698.4M. Notably, Medtronic PLC's price-to-earnings ratio is 24.75x while Intuitive Surgical's PE ratio is 76.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.45x versus 21.60x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Stryker has a net margin of 11.83% compared to Medtronic PLC's net margin of 11.15%. Medtronic PLC's return on equity of 9.51% beat Stryker's return on equity of 14.2%.

Medtronic PLC has a consensus price target of $97.21, signalling upside risk potential of 8.48%. On the other hand Stryker has an analysts' consensus of $422.71 which suggests that it could grow by 8.55%. Given that Stryker has higher upside potential than Medtronic PLC, analysts believe Stryker is more attractive than Medtronic PLC.

Medtronic PLC has a beta of 0.804, which suggesting that the stock is 19.64% less volatile than S&P 500. In comparison Stryker has a beta of 0.915, suggesting its less volatile than the S&P 500 by 8.528%.

Medtronic PLC has a quarterly dividend of $0.71 per share corresponding to a yield of 3.14%. Stryker offers a yield of 0.85% to investors and pays a quarterly dividend of $0.84 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Stryker pays out 40.73% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic PLC quarterly revenues are $8.9B, which are larger than Stryker quarterly revenues of $5.9B. Medtronic PLC's net income of $1.1B is higher than Stryker's net income of $654M. Notably, Medtronic PLC's price-to-earnings ratio is 24.75x while Stryker's PE ratio is 52.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.45x versus 6.47x for Stryker. Usually stocks with elevated PS ratios are considered overvalued.